VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
GeneticVariation
|
BEFREE |
This result suggested that, like those in Caucasian families, the R849W mutation in TIE2 could be one of the major causes for VMCM in Asian families.
|
22621187 |
2012 |
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
GeneticVariation
|
UNIPROT |
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.
|
19888299 |
2010 |
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
GeneticVariation
|
UNIPROT |
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.
|
19079259 |
2009 |
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
GeneticVariation
|
UNIPROT |
Allelic and locus heterogeneity in inherited venous malformations.
|
10369874 |
1999 |
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
GeneticVariation
|
UNIPROT |
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.
|
8980225 |
1996 |
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|
|
0.810 |
CausalMutation
|
CLINVAR |
|
|
|
Congenital abnormality of vein
|
|
0.050 |
GeneticVariation
|
BEFREE |
A <i>TIE2</i> mutation causing arginine-to-tryptophan substitution at residue 849 (<i>TIE2-R849W</i>) is commonly identified in heredofamilial venous malformation.
|
29511374 |
2018 |
Venous malformation
|
|
0.050 |
GeneticVariation
|
BEFREE |
A <i>TIE2</i> mutation causing arginine-to-tryptophan substitution at residue 849 (<i>TIE2-R849W</i>) is commonly identified in heredofamilial venous malformation.
|
29511374 |
2018 |
Venous malformation
|
|
0.050 |
GeneticVariation
|
BEFREE |
In 1996, an arginine-to-tryptophan substitution at position 849 (R849W) in TIE2 was found to induce hereditary VM.
|
28818232 |
2017 |
Congenital abnormality of vein
|
|
0.050 |
GeneticVariation
|
BEFREE |
In 1996, an arginine-to-tryptophan substitution at position 849 (R849W) in TIE2 was found to induce hereditary VM.
|
28818232 |
2017 |
Venous malformation
|
|
0.050 |
GeneticVariation
|
BEFREE |
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
|
23086340 |
2013 |
Congenital abnormality of vein
|
|
0.050 |
GeneticVariation
|
BEFREE |
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
|
23086340 |
2013 |
Venous malformation
|
|
0.050 |
GeneticVariation
|
BEFREE |
Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.
|
18401423 |
2008 |
Congenital abnormality of vein
|
|
0.050 |
GeneticVariation
|
BEFREE |
Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.
|
18401423 |
2008 |
Congenital abnormality of vein
|
|
0.050 |
GeneticVariation
|
BEFREE |
A missense mutation resulting in an arginine-to-tryptophan substitution at position 849 in the kinase domain of the receptor tyrosine kinase TIE2 segregates with dominantly inherited VM in two unrelated families.
|
8980225 |
1996 |
Venous malformation
|
|
0.050 |
GeneticVariation
|
BEFREE |
A missense mutation resulting in an arginine-to-tryptophan substitution at position 849 in the kinase domain of the receptor tyrosine kinase TIE2 segregates with dominantly inherited VM in two unrelated families.
|
8980225 |
1996 |
Vascular anomaly
|
|
0.010 |
GeneticVariation
|
BEFREE |
R849W Tie2 is the most common mutation implicated in an inherited form of vascular malformations and has been shown to be activating, though little is known about the kinetic features of catalysis.
|
30638931 |
2019 |
Adenoviral infections
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we used adenoviral infection to differentiate the effects of ectopic Tie2 (wild type, kinase-dead K855A, or constitutively active R849W) expression on endothelial cellular behaviors and Tie2-mediated downstream targets.
|
18401423 |
2008 |
Hemangiomatosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
The hemangiomatosis was segregated in the dominant fashion in her family, and a germ-line gain-of-function mutation (Arg849Trp) in TIE2 gene was confirmed.
|
16493543 |
2006 |